Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Booth

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioanalysis|November 19, 2010
2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group WorkshopNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphomaBhupinder S Mann, John R Johnson, Kun He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Tristan Massie, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Pemetrexed in malignant pleural mesotheliomaMaitreyee Hazarika, Robert M White, Brian P Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinomaVicki L Goodman, Edwin P Rock, Ramzi Dagher, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioanalysis|November 19, 2010
2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group WorkshopNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphomaBhupinder S Mann, John R Johnson, Kun He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Tristan Massie, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Pemetrexed in malignant pleural mesotheliomaMaitreyee Hazarika, Robert M White, Brian P Booth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinomaVicki L Goodman, Edwin P Rock, Ramzi Dagher, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Pageof 3